Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi, Pakistan.
Department of Surgery, The Aga Khan University, Karachi, Pakistan.
Int J Surg. 2018 May;53:178-183. doi: 10.1016/j.ijsu.2018.03.053. Epub 2018 Mar 27.
Gallbladder cancer (GBC) is a lethal health issue affecting mostly the women in their middle-age. High incidence of GBC has been reported across the world specifically in Asian countries, India and Pakistan. The exact etiology remains unknown, although several risk factors and genetic aberrations involving mutations or epigenetic changes may be involved in gallbladder carcinogenesis. This article presents a review of the published literature mainly from the year 2003 onwards. The topic of main concerns was epigenetic regulation of GBC. All relevant studies identified were included and are described according to the aforementioned subheadings. In this review, we have discussed the role of DNA methylation in GBC, clinical implication and future prospects of biomarker development for early diagnosis and therapeutic interventions.
胆囊癌(GBC)是一种致命的健康问题,主要影响中年女性。全球,尤其是亚洲国家、印度和巴基斯坦的 GBC 发病率很高。尽管涉及突变或表观遗传改变的几种风险因素和遗传异常可能参与胆囊癌的发生,但确切的病因仍不清楚。本文主要综述了 2003 年以来发表的文献。主要关注的问题是 GBC 的表观遗传调控。纳入了所有确定的相关研究,并根据上述副标题进行了描述。在这篇综述中,我们讨论了 DNA 甲基化在 GBC 中的作用、临床意义以及用于早期诊断和治疗干预的生物标志物开发的未来前景。